Liquid-chromatographic determination of urinary 5-hydroxy-3-indoleacetic acid, with fluorescence detection
- PMID: 6173144
Liquid-chromatographic determination of urinary 5-hydroxy-3-indoleacetic acid, with fluorescence detection
Abstract
We describe and evaluate a procedure for measuring urinary 5-hydroxy-3-indoleacetic acid by "high-performance" liquid chromatography. After a simple organic extraction, the analyte and internal standard are chromatographed on a reversed-phase column and are detected by native fluorescence. The detection limit (3 ng per injection), between-day precision (CV 5.2%), absolute recovery (70%), analytical recovery (99%), and working linear range (up to 15 mg/L) have been determined. Compared with colorimetric results with nitrosonaphthol, values obtained with the chromatographic method are significantly lower. Reference values and clinical experience with the method are reported. The method is simple, free from interferences, and suitable for use in routine analysis in the clinical laboratory.
Similar articles
-
Liquid-chromatographic assay of urinary 5-hydroxy-3-indoleacetic acid, with electrochemical detection.Clin Chem. 1980 Jun;26(7):907-9. Clin Chem. 1980. PMID: 6155229
-
Liquid-chromatographic separation of urinary 5-hydroxy-3-indoleacetic acid, with measurement at 254 nm.Clin Chem. 1980 Jun;26(7):910-2. Clin Chem. 1980. PMID: 6155230
-
Colorimetric assay of urinary 5-hydroxy-3-indoleacetic acid.Clin Biochem. 1982 Apr;15(2):106-8. doi: 10.1016/s0009-9120(82)96125-2. Clin Biochem. 1982. PMID: 6178531
-
Simultaneous liquid-chromatographic determination of urinary vanillylmandelic acid, homovanillic acid, and 5-hydroxyindoleacetic acid.Clin Chem. 1988 Dec;34(12):2504-6. Clin Chem. 1988. PMID: 2461816
-
The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid.Postgrad Med J. 1995 Sep;71(839):542-5. doi: 10.1136/pgmj.71.839.542. Postgrad Med J. 1995. PMID: 7479466 Free PMC article. Review.
Cited by
-
Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron.Cancer Chemother Pharmacol. 1995;36(6):477-82. doi: 10.1007/BF00685797. Cancer Chemother Pharmacol. 1995. PMID: 7554039
-
Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.Br J Cancer. 1992 Nov;66(5):850-5. doi: 10.1038/bjc.1992.372. Br J Cancer. 1992. PMID: 1384643 Free PMC article. Clinical Trial.